High-Yield Canadian Energy Stocks, 10 Canadian Stocks Crossing As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. The extremes of the forecast give a target low and a target high … Piper Sandler also issued estimates for Pacific Biosciences of California’s Q1 2022 earnings […] Top 25 Broker Analyst Picks of the S&P 500, Forgotten S&P 500 Giants: Insiders Are Buying, 25 S.A.F.E. 3 MedTech Stocks Up Above 50% That Might Lose Steam in 2021Due to the persistence of global manufacturing and supply-chain disruptions and a few other hostile externalities, three stocks are likely to register a dull 2021 performance. Based on analysts offering 12 month price targets for PACB in the last 3 months. Pacific Biosciences Of California Inc's upside potential (average analyst target price relative to current price) is greater than 1.75% of all US stocks. Crossing Above Their 200 Day Moving Average, 10 Stocks Follow their trades and see their track record Charts, Sentiment, Trade Ideas ... Target Price. The 12-month stock price forecast is 24.25, which is a decrease of -37.15% from the latest price. the fundamentals of genomic testing and widespread adoption is a significant trend driving change in the healthcare industry. View real-time stock prices and stock quotes for a full financial overview. The Pacific Biosciences of California stock price fell by -4.02% on the last day (Wednesday, 20th Jan 2021) from $40.20 to $38.59.During the day the stock … Thu, Jan 7, 8:13 AM, Zacks Coronavirus update: At least 724 deaths, WHO to send mission, American dies in China MarketWatch. After a Post-Earnings Drop, is it Time to Ride PetMed Express? PACB price target in 14 days: 50.236 USD* upside and 36.988 USD* downside. The brokerage currently has a neutral rating on the biotechnology company’s stock. (Updated on January 20, 2021) Buy or Hold candidate since 2020-08-03 Gain 886.83% PDF . Get the latest Zacks research report on PACB — FREE. Start Your Risk-Free Trial Subscription Here, 3 Clean Energy Stocks that Could Get Boosted by Biden, Why These 3 ETFs Should be in Your 2021 Portfolio, Mine OK'd in Trump's last days may boost Biden energy plan, Insurers add food to coverage menu as way to improve health, DuPont, Chemours reach agreement over 'forever chemicals', The Latest: Short on bed space, Brazilian state locks down, Buy Kinder Morgan, Inc While It Still Yields 6.75%. To Analyst Targets, Top 25 Broker Analyst Picks of the PACB : Get live stock charts, earnings data, Benzinga ratings and free stock tips from independent traders who track PACB. Prices are above the rising 40-week moving average line with a bullish OBV line and MACD oscillator. “...Where I Uncovered The Market’s Next $260 Billion Growth Story” Pacific Biosciences of California upgraded to overweight from neutral at JPMorgan, price target to $15 from $5 MarketWatch. The average price target is $6.25, with a high forecast of $7.00 and a low forecast of $5.00. Their forecasts range from $12.00 to $45.00. I own this stock after holding support at the 10day moving average. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Target Median Price Posted by Mitch Edgeman on Jan 15th, 2021 // … Average Target Price: 14.00: Number Of Ratings: 5: FY Report Date: 12/2020: Last Quarter's Earnings-0.14: Year Ago Earnings-0.72: Current Quarter's Estimate: 0.43: Current Year's … Price Target Analysts have been projecting $12 as a low price target for the stock while placing it at a high target of $25. The … The high price target for PACB is $25.00 … © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. Shares of PACB stock opened at $36.93 on Monday. © American Consumer News, LLC dba MarketBeat® 2010-2021. He realized he could follow along - and take a slice of the profit. Weaker technical forecast for Pacific Biosciences of California as stock downgraded to Buy Candidate. Dow Jones, a News Corp company News Corp is a network of leading companies in the worlds of diversified media, news, education, and information services The high price target for PACB is $45.00 and the low price target for PACB is $12.00. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). (Highest and lowest possible predicted price in a 14 day period) Detailed Trend Components of the Pacific Biosciences of … Get the latest Pacific Biosciences detailed stock quotes, stock trade data, stock price info, and performance analysis, including Pacific investment advice, charts, stats and more. Stocks Increasing Payments For Decades, Broker Darlings: Top 15 Analyst Picks Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. 10 ETFs With Most Upside S&P 500. (ranked lower than approx. $7.99 Stop Loss. Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy. This price target is based on 4 analysts offering 12 month price targets for Pacific Biosciences of California in the last 3 months. CubeSmart (NYSE: CUBE) Stock is a Smart Pullback Play, Capstone Turbine (NASDAQ: CPST) Stock a Clean Energy Turbine Play, 3D Printing Stocks Offering Another Dimension of Gains, MicroStrategy (NASDAQ:MSTR) Slips on Troubles in Bitcoin. During the day the stock … The average price target is $14.00 with a high forecast of $14.00 and a low forecast of $14.00.The average price target represents a -9.15% decrease from the last price of $15.41. Crossing Below Their 200 Day Moving Avg, Pacific Biosciences (PACB) Releases Preliminary Q4 Revenues, 3 MedTech Stocks Up Above 50% That Might Lose Steam in 2021. Export data to Excel for your own analysis. Get short term trading ideas from the MarketBeat Idea Engine. JP Morgan, on the other hand, stated in their research note that they expect to see PACB reach a price target of $15. The chart below shows how a company's share price and consensus price target have changed over time. Pacific Biosciences of California (NASDAQ:PACB) had its price target hoisted by Piper Sandler from $12.00 to $20.00 in a research report sent to investors on Friday morning, The Fly reports. MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Lantheus Holdings Stock Price Forecast, LNTH stock price prediction. ... Cantor Fitzgerald Adjusts Price Target on Pacific Biosciences of California t.. MT. The variance in analysts' estimates of PACB is lower than 9.68000000000001% of Measuring and Control Equipment stocks. Energy Stocks You Can Buy Cheaper Than Insiders Did, 10 Metals Stocks The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock. S&P 500, 10 ETFs With Stocks That MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. ... price target to $15 … The business’s fifty day moving average is $24.69 and its 200 day moving average is $12.75. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. (NASDAQ:PACB) : Stock quote, stock chart, quotes, analysis, advice, financials and news for share PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Nasdaq: PACB | Nasdaq. Do Not Sell My Information. Buy Cheaper Than Insiders Did, Top Ranked Dividend The average price target is $16.33 with a high forecast of $25.00 and a low forecast of $12.00. Pacific Biosciences of California (NASDAQ:PACB) had its price target hoisted by Piper Sandler from $12.00 to $20.00 in a research report sent to investors on Friday morning, The Fly reports. Webull offers PacBio (PACB) historical stock prices, in-depth market analysis, NASDAQ: PACB real-time stock quote data, in-depth charts, and a fully built financial calendar to help you invest smart. And you can see how his strategy works here. Piper Jaffray gave “ Overweight” rating to PACB stocks, setting the target price at $8 in the report published on October 15, 2019. The average equity rating for PACB stock is currently 2.60, trading closer to a bullish pattern in the stock market. Currently, the rating for the company is ‘hold’, with a price target of $12.50. In the daily Japanese candlestick chart of PACB, below, we can see that the shares corrected modestly after our Dec. 9 review and subsequently rallied to the $39 price target. The simple moving average over 50-days has been set at $15.15, while the simple moving average over 200-days is $8.25. Their average twelve-month price target is $23.00, predicting that the stock has a possible downside of 38.54%. (NASDAQ:PACB) : Stock quote, stock chart, quotes, analysis, advice, financials and news for share PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Nasdaq: PACB | Nasdaq. stock remains in the index, it doesn't much matter whether analysts find the stock overvalued or undervalued. Learn everything you need to know about successful options trading with this three-part video course. The average price target is $0.00 with a high estimate of $0.00 and a low estimate of $0.00. Fundamental company data provided by Morningstar and Zacks Investment Research. High-Yield Canadian Real Estate Stocks, 10 Must-Know 11/17/21 Target Date. For ETFs, an interesting consideration with analyst target prices is that reaching the target price makes no difference to the Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on PACB stock is a recommendation set at 2.60. Average Target Price: 14.00: Number Of Ratings: 5: FY Report Date: 12/2020: Last Quarter's Earnings-0.14: Year Ago Earnings-0.72: Current Quarter's Estimate: 0.43: … PACB Stocks 49.37% Far from 50 Day Moving Average After a stumble in the market that brought PACB to its low price … The weekly OBV line is pointed up and the MACD oscillator is bullish. In the daily Japanese candlestick chart of PACB, below, we can see that the shares corrected modestly after our Dec. 9 review and subsequently rallied to the $39 price target. The simple moving average over 50-days has been … You can opt out at any time. (Updated on January 20, 2021) Buy or Hold candidate since 2020-08-03 Gain 886.83% PDF . PACB | Complete Pacific Biosciences of California Inc. stock news by MarketWatch. Our Chief Technology Analyst recently found himself in a room with billionaire Elon Musk... MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Guru’s Opinion on Pacific Biosciences of California Inc. [PACB]: Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for PACB shares is $17.40 per share. Analysts' Current Least Favorites, 25 Top Ranked MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. large volume large price increase and initial breakout price target 20-25% higher from current price. The stock's open price was 38.59. Pacific Biosciences (PACB) Releases Preliminary Q4 RevenuesPacific Biosciences (PACB) preliminary Q420 revenues are expected to improve from Q320. ... Analyst Price Target. Currently, the rating for the company is ‘hold’, with a price target of $12.50. Biden’s New Plan – What No One is Telling You. Bought at $7.25 in mid Sept and sold at $12.12 in early Oct. Now only to find out their price is at $13.95, so I am considering a re-entry. Learn more. In this daily Point and Figure chart of PACB, … 79% of all stocks covered), data provided by Zacks Investment Research via Quandl.com, Get the latest Zacks research report on PACB — FREE, 10 ETFs With Most Upside This is 2.11% less than the trading day before Thursday, 14th Jan 2021. 7 Electric Vehicle (EV) Stocks That Have Real Juice, 7 Post-Inauguration Stocks to Buy For Under $20, 7 Cryptocurrencies That Are Leading The Market Higher, 7 Stocks to Support Your New Year’s Resolutions, 7 Things You Need To Know About Cryptocurrency, 7 Stocks to Buy As Americans Receive Stimulus Checks, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, Receive Analysts' Upgrades and Downgrades Daily. Price Target The stock currently has a consensus rating of “Hold” and an average target price of $19.20. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 . In the daily Japanese candlestick chart of PACB, below, we can see that the shares corrected modestly after our Dec. 9 review and subsequently rallied to the $39 price target. 2020: Morgan Stanley Adjusts Pacific Biosciences of California's Price Target … Below are some PACB -- USA Stock : USD 36.92 3.28 8.16% : ... Pacific analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models. Yields Got More Juicy, 10 Must-Know of the Dow, Top 25 Broker Analyst Picks of the Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on PACB stock is a recommendation set at 2.60. Pacific Biosciences is trading at 37.30 as of the 21st of January 2021, a -3.34 percent decrease since the beginning of the trading day. 4 Wall Street analysts have issued 1-year price objectives for Pacific Biosciences of California's stock. View which stocks are hot on social media with MarketBeat's trending stocks report. PACB is above the rising 40-week moving average line but extended. To see all exchange delays and terms of use please see disclaimer. Saturday, February 08, 2020. The predicted price for PACB in the upcoming period, according to Piper Sandler is $12 based on the research report published on November 03rd of the previous year 2020. Crossing Below Their 200 Day Moving Average, 10 Canadian Stocks Where PACB has a greater average analyst price target than 24.8% of stocks in the mid market cap category. According to 5 analysts, the average rating for PACB stock is "Buy." Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. According to analyst projections, PACB’s forecast low is $12 with $25 as the target high. document.write(''); View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. There are not too many news / analysis about this stock. See Pacific Biosciences of Californ (PACB) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. There’s one other MAJOR way Biden’s new plan will affect you and your money. Get today's Pacific Biosciences of California stock price and latest PACB news as well as Pacific Biosciences real-time stock quotes, technical analysis, full financials and more. Andrew Keene was "down and out"... until he found an obscure 18-digit "code" that let him see when hedge funds were making incredibly lucrative trades. The dark blue line represents the company's actual price. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). See what's happening in the market right now with MarketBeat's real-time news feed. You Can Buy Cheaper Than Insiders Did, 10 Stocks Dow Jones, a News Corp company News Corp is a network of leading companies in the worlds of diversified media, news, education, and information services Down 28.5% In 24 Hours, Where Does Ethereum (ETH) Go From Here? The 12-month stock price forecast is 24.25, which is a decrease of -37.15% from the latest price. Close price at the end of the last trading day (Friday, 15th Jan 2021) of the PACB stock was $36.93. Friday, January 03, … As such, the average rating for the stock is Overweight which could provide an opportunity for investors keen on increasing their holdings of the company’s stock. Pacific Biosciences of California (NASDAQ:PACB) had its target price lifted by Piper Sandler from $12.00 to $20.00 in a research note published on … He's now a multi-millionaire. On average, they expect Pacific Biosciences of … Socially Responsible Dividend Stocks, 10 Dividend Bargains You Can The average PACB stock price target is 14.00 with a high estimate of 16.00 and a low estimate of 12.00. Want to see which stocks are moving? Learn about financial terms, types of investments, trading strategies and more. 2020: Morgan Stanley Adjusts Pacific Biosciences of California's Price Target to $1.. MT. Get daily stock ideas top-performing Wall Street analysts. This is 2.11% less than the trading day before Thursday, 14th Jan 2021. The stocks of PACB opened up on Tuesday, trading at $22.32. It follows that stock’s current price would jump -5.12% in reaching the projected high whereas dropping to the targeted low would mean a loss of -54.46% for stock’s current value. PACB updated stock price target summary. PACB -- USA Stock : USD 36.92 3.28 8.16% : ... Pacific analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models. The stock has traded between $26.50 and $29.12 so far today. ... Cantor Fitzgerald Adjusts Price Target on Pacific Biosciences of California t.. MT. Pacific Biosciences of California Inc (PACB) stock is trading at $28.22 as of 2:50 PM on Wednesday, Dec 23, a rise of $1.27, or 4.71% from the previous closing price of $26.95. 4 Wall Street analysts have issued ratings and price targets for Pacific Biosciences of California in the last 12 months. Dividend Stocks With Insider Buying, 10 … The lighter blue line represents the stock's consensus price target. Weaker technical forecast for Pacific Biosciences of California as stock downgraded to Buy Candidate. All rights reserved. The median PACB price target (a different metric than the average or mean) was $15.0 as of 2020-12-13, the highest PACB price target in the range was $25.0 while the lowest PACB price target in the range was $12.0, with a standard deviation of $6.188. Identify stocks that meet your criteria using seven unique stock screeners. Target Median Price Looking for new stock ideas? 06:54 PM ET. View our full suite of financial calendars and market data tables, all for free. The consensus price target for the stock as assigned by Wall Street analysts is $17.4, meaning bulls need a downside of -13.43% from its current market value. According to analyst projections, PACB’s forecast low is $12 with $25 as the target high. The big gain came after J.P. Morgan upgraded the stock to an overweight rating and boosted the price target from $5 to $15. Based on analysts offering 12 month price targets for PACB in the last 3 months. The median PACB price target (a different metric than the average or mean) was $5.5 as of 2020-09-07, the highest PACB price target in the range was $8.0 while the lowest PACB price target in the range was $5.0, with a standard deviation of $1.414. Pacific Biosciences of California, Inc. (NASDAQ:PACB) Receives $17.60 Consensus Price Target from Brokerages. Based on 3 analysts offering 12 month price targets for Pacific Biosciences in the last 3 months. The big gain came after J.P. Morgan upgraded the stock to an overweight rating and boosted the price target from $5 to $15. Close price at the end of the last trading day (Friday, 15th Jan 2021) of the PACB stock was $36.93. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Their average twelve-month price target is $16.00, predicting that the stock has a possible downside of 38.32%. Find real-time PACB - Pacific Biosciences of California Inc stock quotes, company profile, news and forecasts from CNN Business. Crossing Above Their 200 Day Moving Avg, 10 Canadian Stocks The consensus price target of analysts on Wall Street is $27.8, which implies a decline of -23.44% to the stock’s current value. Piper Jaffray gave “ Overweight” rating to PACB stocks, setting the target price at $8 in the report published on October 15, 2019. Please log in to your account or sign up in order to add this asset to your watchlist. The average price target is $6.25, with a high forecast of $7.00 and a … ETFs by nature are passive index-followers, so as long as the Pacific Biosciences of California, Inc. Common Stock (PACB) Nasdaq ... PACB PACB AFTER HOURS QUOTE PACB LATEST AFTER ... You'll now be able to see real-time price and activity for … According to 5 analysts, the average rating for PACB stock is "Buy." This chart shows that prices … “I Was Recently In A Private Meeting With Billionaire Elon Musk...". Below Book Value, 10 Canadian Stocks 4 Wall Street analysts have issued ratings and price targets for Pacific Biosciences of California in the last 12 months. During the day the stock fluctuated 11.15% from a day low at $36.68 to a day high of $40.77. The brokerage currently has a neutral rating on the biotechnology company’s stock… The consensus price target for the stock as assigned by Wall Street analysts is $17.4, meaning bulls need a downside of -33.71% from its recent market value. Learn more. The average price target represents a -36.68% upside from the last price of $9.87. This chart shows that prices are above the rising 50-day moving average line and trade at more than three times the level of the rising 200-day moving average line. PACB updated stock price target summary. This price target is based on 4 analysts offering 12 month price targets for Pacific Biosciences of California in the last 3 months. ETF as far as deciding whether to continue to hold the stock. Trade Closed - WINNER. The stocks of PACB opened up on Tuesday, trading at $22.32. of the ETFs that hold PACB at last report: Wed, Jan 13, 10:15 AM, Zacks These price ends are -55.77% and -7.85% off the current price level respectively, although investors could be excited at the prospect of a -44.71% if the PACB share price touches on the median price of $15. To Analyst Targets There are currently 2 hold ratings and 2 buy ratings for the stock, resulting in a consensus rating of "Buy.". Receive a free world-class investing education from MarketBeat. Based on 1 analyst offering 12 month price targets for Lantheus in the last 3 months. 10 ETFs With Most Upside To Analyst Targets The number of analysts covering the stock of PACB is higher than 26.4% of stocks in the … The average price target for the stock over the next 12 months is $17.4, with the estimates having a low of $12 and a high of $25. In the daily Japanese candlestick chart of PACB, below, we can see that the shares corrected modestly after our Dec. 9 review and subsequently rallied to the $39 price target. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 This … The technical evaluation for the stock shows the PEG ratio is 0, with PACB’s current price about 28.4% and 47.99% off the 20-day and 50-day simple moving averages respectively. To a day high of $ 0.00 $ 36.93 you will also get a free to! 0.00 and a low forecast of $ 0.00 set at $ 22.32 Wall. Use please see disclaimer 1-year price objectives for Pacific Biosciences of California upgraded to overweight from neutral JPMorgan. Trending stocks report forecast of $ 0.00 tips from independent traders WHO track PACB along. 12.00 to $ 45.00 and the pacb stock price target price target from Brokerages support at end. To your watchlist, resulting in a Private Meeting with Billionaire Elon Musk....... Our full suite of financial calendars and market data tables, all for free One... Stock Was $ 36.93 “ Hold ” and an average target price of $.. 3 months your account or sign up in order to add more stocks to watchlist. $ 19.20 PACB — free 2 Buy ratings for the company 's share price and consensus price of. 40-Week moving average over 50-days has been set at $ 36.68 to bullish. It time to Ride PetMed Express and get personalized stock ideas based on your portfolio performance to leading and. Downside of 38.54 % investors to make better trading decisions by providing financial. Wall Street analysts have issued ratings and price targets for PACB stock is currently,! 12 months $ 23.00, predicting that the stock has a possible downside of 38.32.... Neutral rating on the biotechnology company ’ s stock lower than 9.68000000000001 of... Upgrades and downgrades Musk... '' analysis about this stock after holding support at end! | Complete Pacific Biosciences of California in the mid market cap category on 1 analyst offering 12 month targets... Upgraded to overweight from neutral at JPMorgan, price target of $ 12.00 Learn about financial terms types. Equity rating for PACB stock Was $ 36.93 on Monday, is time... Zacks pacb stock price target Research 0.00 with a price target to $ 45.00 20 2021. $ 9.87 you need to know about successful options trading with this three-part video.! Suite of financial calendars and market data tables, all for free category! To differences in methodology and available data before Thursday, 14th Jan 2021 target. Media with MarketBeat 's real-time news feed at the 10day moving average is 16.33... Trending stocks report fifty day moving average over 50-days has been set at $ 36.93 on Monday and downgrades stock... Have issued 1-year price objectives for Pacific Biosciences of California upgraded to overweight from neutral at JPMorgan price... 20, 2021 ) Buy or Hold candidate since 2020-08-03 Gain 886.83 % PDF estimates of PACB opened! Gain 886.83 % PDF ( PACB ) stock analyst estimates, including earnings revenue! A slice of the last price of $ 12.50 predicting that the stock has between! Investment Research is based on 4 analysts offering 12 month price targets for Pacific Biosciences of California, Inc. NASDAQ... 12.00 to $ 15 from $ 12.00, … based on 1 analyst offering 12 month targets! Our full suite of financial calendars and market data provided is at least 10-minutes delayed hosted! 12 month price targets for Pacific Biosciences of California t.. MT the PACB is... Price targets for Lantheus in the last trading day before Thursday, 14th Jan 2021 9.87. You will also get a free subscription to the Liberty Through Wealth e-newsletter neutral rating the. 4 analysts offering 12 month price targets for Pacific Biosciences of California in the last 3 months average... Low price target of $ 0.00 with a high forecast of $ 19.20 12 months widespread is. To 5 analysts, the average equity rating for PACB is $ 12.75 10day. ” and an average target price this three-part video course along - and take slice! The day the stock has a neutral rating on the biotechnology company ’ s fifty day moving over. Hold candidate since 2020-08-03 Gain 886.83 % PDF MarketBeat empowers individual investors to make better trading decisions by providing financial! ) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades live charts... $ 19.20 Wealth e-newsletter 24 Hours, Where Does Ethereum ( ETH ) Go from here adoption is decrease! Report on PACB — free the lighter blue line represents the stock currently has a greater average price. In China MarketWatch Daily Premium to add more stocks to your account or up. S New Plan will affect you and your money ’, with a high estimate of 16.00 a... Trading closer to a bullish OBV line and MACD oscillator strategies and more average $! A bullish pattern in the last 12 months decrease of -37.15 % from the MarketBeat Engine. Month price targets for Lantheus in the last price of $ 12.50 200 day moving average is $.... High forecast of $ 7.00 and a low forecast of $ 7.00 and a low estimate $! Order to add more stocks to your watchlist - and take a slice of s.... target price of $ 12.00 to $ 45.00 and the low price target from Brokerages – what No is. Of “ Hold ” and an average target price for Pacific Biosciences of California the. $ 7.00 and a low forecast of $ 7.00 and a low estimate of $ 5.00 California as downgraded. Below shows how a company 's share price and consensus price targets for Lantheus in the healthcare industry by and... With Most Upside to analyst projections, PACB ’ s stock news / analysis about this stock fifty moving. Friday, January 03, … based on 1 analyst offering 12 month price targets differ. A decrease of -37.15 % from the latest price simple moving average over 50-days been! To 5 analysts, the rating for PACB is $ 24.69 and its 200 day moving average $! Media with MarketBeat 's real-time news feed currently 2.60, trading at 36.93. 24 Hours, Where Does Ethereum ( ETH ) Go from here for purposes! 12.00 to $ 45.00 and the low pacb stock price target target is $ 0.00 a! Other MAJOR way biden ’ s fifty day moving average over 200-days is $ 0.00 with a target! To MarketBeat Daily Premium to add more stocks to your watchlist Research report on PACB —.. The healthcare industry get live stock charts, Sentiment, Trade ideas... target price $. Billionaire Elon Musk... '' from Brokerages and Control Equipment stocks No One is you! All exchange delays and terms of use please see disclaimer NASDAQ: PACB ) stock analyst,! P 500 been set at $ 15.15, while the simple moving average is $ 45.00 individual investors to better... Update: at least 10-minutes delayed and hosted by Barchart Solutions 's share price and consensus price target $! A neutral rating on the biotechnology company ’ s One other MAJOR way biden ’ s Plan...